The immunodominant, Ld-restricted T cell response to hepatitis B surface antigen (HBsAg) efficiently suppresses T cell priming to multiple Dd-, Kd-, and Kb-restricted HBsAg epitopes

Journal of Immunology

Volumn 168, Issue 12, 2002, Pages 6253-6262

  Schirmbeck, Reinhold ^a   Stober, Detlef ^a   El Kholy, Shereen ^a   Riedl, Petra ^a   Reimann, Jörg ^a  

^a UNIVERSITY OF ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DNA VACCINE; EPITOPE; HEPATITIS B SURFACE ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; H2 ANTIGEN; HISTOCOMPATIBILITY ANTIGEN H 2D(B); HISTOCOMPATIBILITY ANTIGEN H-2D(B); PEPTIDE FRAGMENT;

ALLELE; ANIMAL CELL; ANTIGEN PRESENTATION; ARTICLE; CONGENIC STRAIN; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; GENETIC TRANSFECTION; IMMUNE RESPONSE; IMMUNOREACTIVITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; VACCINATION; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; C57BL MOUSE; CELL CULTURE; CHICKEN; CYTOTOXICITY; CYTOTOXICITY TEST; DBA MOUSE; FEMALE; GENETICS; IMMUNOLOGY; IMMUNOSUPPRESSIVE TREATMENT; INNATE IMMUNITY; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; METABOLISM; METHODOLOGY; PLASMID; SYNTHESIS;

ANIMALS; ANTIGEN PRESENTATION; CHICKENS; CYTOTOXICITY TESTS, IMMUNOLOGIC; CYTOTOXICITY, IMMUNOLOGIC; EPITOPES, T-LYMPHOCYTE; FEMALE; H-2 ANTIGENS; HEPATITIS B SURFACE ANTIGENS; IMMUNITY, NATURAL; IMMUNODOMINANT EPITOPES; IMMUNOSUPPRESSION; INJECTIONS, INTRAMUSCULAR; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, INBRED DBA; PEPTIDE FRAGMENTS; PLASMIDS; T-LYMPHOCYTES, CYTOTOXIC; TUMOR CELLS, CULTURED; VACCINATION; VACCINES, DNA;

EID: 0037096206     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.168.12.6253     Document Type: Article

References (32)

1. Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses
2. Dissecting the multifactorial causes of immunodominance in class I-restricted T cell responses to viruses
3. Polyclonality and multispecificity of the CTL response to a single viral epitope
4. Overcoming T cell tolerance to the hepatitis B virus surface antigen in hepatitis B virus-transgenic mice
5. Similar as well as distinct MHC-I-binding peptides are generated by exogenous and endogenous processing of hepatitis B virus surface antigen (HBsAg)
6. DNA vector constructs that prime hepatitis B surface antigen-specific cytotoxic T lymphocyte and antibody responses in mice after intramuscular injection
7. d mice that reject syngeneic tumors
8. b-restricted peptide presentation
9. Truncated or chimeric endogenous protein antigens gain immunogenicity for B cells by stress protein-facilitated expression
10. Simultaneous expression of the S and L surface antigens of hepatitis B, and formation of mixed particles in the methylotrophic yeast, Hansenula polymorpha
11. Comparison between surface antigen (HBsAg) particles derived from mammalian cells (CHO) and yeast cells (Hansenula polymorpha): Composition, structure and immunogenicity
12. Immunobiology and pathogenesis of hepatocellular injury in hepatitis B virus transgenic mice
13. Ongoing murine T1 or T2 immune responses to the hepatitis B surface antigen are excluded from the liver that expresses transgene-encoded hepatitis B surface antigen
14. Peptide transporter-independent, stress protein-mediated endosomal processing of endogenous protein antigens for major histocompatibility complex class I presentation
15. DNA-mediated immunization in mice induces a potent MHC class I-restricted cytotoxic T lymphocyte response to the hepatitis B envelope protein
16. Alternative pathways for processing exogenous and endogenous antigens that can generate peptides for MHC class I-restricted presentation
17. Adjuvants that enhance priming of cytotoxic T cells to a Kb-restricted epitope processed from exogenous but not endogenous hepatitis B surface antigen
18. In vitro expansion distorts the detectable pattern of specific recognition of in vivo primed cytotoxic T lymphocyte populations
19. DNA vaccines
20. DNA vaccines: Immunology, application and optimization
21. Hepatitis B virus small surface antigen particles are processed in a novel endosomal pathway for major histocompatibility complex class I-restricted epitope presentation
22. d molecules capture peptides from endocytosed hepatitis B surface antigen particles for major histocompatibility complex class I-restricted presentation
23. d-restricted epitope presentation depends on exogenous β2-microglobulin
24. + T cell responses to infectious agents, tumors, transplants, and vaccines
25. Simian immunodeficiency virus evades a dominant epitope-specific cytotoxic T lymphocyte response through a mutation resulting in the accelerated dissociation of viral peptide and MHC class I
26. + T cell response during acute and persistent murine γ-herpesvirus infection
27. b-restricted epitopes and reversal by dendritic cell-mediated antigen delivery
28. Immunodominance in the CTL response against minor histocompatibility antigens: Interference between responding T cells, rather than with presentation of epitopes
29. + T lymphocyte differentiation as a mechanism for subdominant cytotoxic T lymphocyte responses to a viral antigen
30. Recombinant polyepitope vaccines for the delivery of multiple CD8 cytotoxic T cell epitopes
31. A multivalent minigene vaccine, containing B-cell, cytotoxic T-lymphocyte, and Th epitopes from several microbes, induces appropriate responses in vivo and confers protection against more than one pathogen
32. Utilization of MHC class I transgenic mice for development of minigene DNA vaccines encoding multiple HLA-restricted CTL epitopes